Business Context and Reporting Period
This Form 8-K is a current report filed by Aikido Pharma Inc. (not Dominari Holdings Inc. as indicated in metadata) on August 31, 2020. The registrant is a Delaware corporation with its principal executive offices in New York, NY. The filing reports on the issuance of a presentation deck summarizing the Company's current drug products for the LD Micro 500 Conference scheduled for September 3, 2020.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event (Item 8.01) and does not contain financial statements or quantitative financial data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely discloses the release of a presentation deck as an "Other Event."
Guidance, Outlook, and Risks
The Company issued a presentation deck (Exhibit 99.1) to summarize its current drug products for an upcoming industry conference. The filing does not contain specific management commentary on financial guidance, outlook, risks, contingencies, or unusual items beyond the reference to the attached presentation.
Investor Verification Checklist
- Verify the content of the attached Exhibit 99.1 (Presentation dated August 31, 2020) for details on drug product status.
- Confirm the Company's ticker symbol is AIKI on The Nasdaq Capital Market.
- Note that this filing does not contain audited or unaudited financial results; refer to the most recent 10-K or 10-Q for financial metrics.